Literature DB >> 31493649

p-STAT1 regulates the influenza A virus replication and inflammatory response in vitro and vivo.

Shouping Zhang1, Caiyun Huo1, Jin Xiao2, Tao Fan1, Shumei Zou3, Peng Qi2, Lunquan Sun4, Ming Wang5, Yanxin Hu6.   

Abstract

Influenza A virus infection activates various intracellular signaling pathways, which is mediated by the transcription factors. Here, a quantitative phosphoproteomic analysis of A549 cells after infection with influenza A virus (H5N1) was performed and we found that the transcription factor STAT1 was highly activated. Unexpectedly, upon inhibition of p-STAT1, titers of progeny virus and viral protein synthesis were both reduced. The STAT1 inhibitor Fludarabine (FLUD) inhibited an early progeny step in viral infection and reduced the levels of influenza virus genomic RNA (vRNA). Concomitantly, there was reduced expression of inflammatory cytokines in p-STAT1 inhibited cells. In vivo, suppression of p-STAT1 improved the survival of H5N1 virus-infected mice, reduced the pulmonary inflammatory response and viral burden. Thus, our data demonstrated a critical role for p-STAT1 in influenza virus replication and inflammatory responses. We speculate that STAT1 is an example of a putative antiviral signaling component to support effective replication.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fludarabine; Inflammation; Influenza a virus; STAT1; Virus genomic RNA

Mesh:

Substances:

Year:  2019        PMID: 31493649     DOI: 10.1016/j.virol.2019.08.023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy.

Authors:  Colin H Quinn; Andee M Beierle; Sara Claire Hutchins; Raoud Marayati; Laura V Bownes; Jerry E Stewart; Hooper R Markert; Michael H Erwin; Jamie M Aye; Karina J Yoon; Gregory K Friedman; Christopher D Willey; James M Markert; Elizabeth A Beierle
Journal:  Cancers (Basel)       Date:  2022-02-01       Impact factor: 6.575

2.  Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation.

Authors:  Xiaoming Liu; Xiang Li; Ling Chen; Alan Chen-Yu Hsu; Kelly L Asquith; Chi Liu; Karen Laurie; Ian Barr; Paul S Foster; Ming Yang
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

3.  H1N1 influenza virus dose dependent induction of dysregulated innate immune responses and STAT1/3 activation are associated with pulmonary immunopathological damage.

Authors:  Duoduo Yao; Linlin Bao; Fengdi Li; Bo Liu; Xu Wu; Ziqi Hu; Jiangnan Xu; Wei Wang; Xulong Zhang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

4.  MicroRNA-206 inhibits influenza A virus replication by targeting tankyrase 2.

Authors:  Gayan Bamunuarachchi; Xiaoyun Yang; Chaoqun Huang; Yurong Liang; Yujie Guo; Lin Liu
Journal:  Cell Microbiol       Date:  2020-11-04       Impact factor: 3.715

5.  Structural and Biological Basis of Alphacoronavirus nsp1 Associated with Host Proliferation and Immune Evasion.

Authors:  Zhou Shen; Yiling Yang; Siqi Yang; Guangxu Zhang; Shaobo Xiao; Zhen F Fu; Guiqing Peng
Journal:  Viruses       Date:  2020-07-28       Impact factor: 5.048

6.  In Vitro and In Vivo Antiviral Activity of Gingerenone A on Influenza A Virus Is Mediated by Targeting Janus Kinase 2.

Authors:  Jiongjiong Wang; Richard A Prinz; Xiufan Liu; Xiulong Xu
Journal:  Viruses       Date:  2020-10-08       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.